Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.775 USD | -3.91% | -7.58% | -11.16% |
May. 20 | Foghorn Therapeutics Prices $110 Million Offering of Shares, Pre-Funded Warrants | MT |
May. 06 | Foghorn Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.16% | 333M | |
+18.94% | 125B | |
+13.87% | 108B | |
-7.59% | 24.21B | |
+2.07% | 22.78B | |
-10.79% | 17.96B | |
-41.74% | 16.43B | |
-13.94% | 16.37B | |
+2.41% | 13.58B | |
+27.84% | 11.66B |
- Stock Market
- Equities
- FHTX Stock
- News Foghorn Therapeutics Inc.
- Wedbush Cuts Price Target on Foghorn Therapeutics to $25 From $32, Citing FHD-286 Clinical Hold; Outperform Rating Kept